Trial of AEO in New Glioblastoma (GBM)
NCT04450160
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
DRUG:
Anhydrous Enol-Oxaloacetate (AEO)
OTHER:
Standard of Care
Sponsor
MetVital, Inc.